NanoFerix has signed an agreement with Vanderbilt's Center for Technology Transfer and Commercialization to research technology to market to pharmaceutical companies.
US-based Vanderbilt University’s technology transfer program has signed its first local start-up in more than two years by backing serial entrepreneur Shawn Glinter’s NanoFerix. NanoFerix has signed an agreement with Vanderbilt’s Center for Technology Transfer and Commercialization to research technology to market to pharmaceutical companies.
The rest of this content is only accessible to Global Venturing Subscribers.
This content is only accessible to subscribers. If you are a subscriber, please sign in. Otherwise, if you would like to try before you buy and haven't previously taken out a free trial, you can do so below. You can also see details on subscriptions by clicking the Subscription Options button.
